SCHEMBL27804142

SCHEMBL27804142

NC(=O)c1ccnc(CC(=O)c2ccnc(Cl)c2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 2/20 0.42
NPC1 O15118 1/20 0.42
MBOAT4 Q96T53 1/20 0.40
CDK8 P49336 2/20 0.40
CCNC P24863 1/20 0.40
KDM5C P41229 2/20 0.39
KDM5B Q9UGL1 2/20 0.39
KDM5A P29375 1/20 0.39
KDM5D Q9BY66 1/20 0.39
KDM4C Q9H3R0 1/20 0.39
CYP1A2 P05177 1/20 0.39
POLB P06746 1/20 0.39
KDM4E B2RXH2 1/20 0.38
LMNA P02545 1/20 0.38
CYP3A4 P08684 1/20 0.38
TSHR P16473 1/20 0.38
KDM4B O94953 1/20 0.38
SMARCA2 P51531 2/20 0.37
SMARCA4 P51532 2/20 0.37
MAP4K4 O95819 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29642415 0.84 CCNC (0.50) CDK8CCNCKDM5CKDM5BKDM4B
SCHEMBL1569241 0.84 CCNC (0.50) CDK8CCNCKDM5CKDM5BKDM4B
SCHEMBL3863943 0.82 CCNC (0.49) CDK8CCNCKDM5CKDM5BKDM4B
Hydrochloric Acid SCHEMBL14759172 0.82 CCNC (0.49) CDK8CCNCKDM5CKDM5BKDM4B
Butyramide SCHEMBL27747635 0.78 LMNA (0.42) CDK8CCNCKDM5CKDM5BKDM5A
SCHEMBL2257182 0.78 RAB9A (0.40) RAB9ANPC1CDK8CCNCSMARCA2
SCHEMBL5566822 0.76 CYP1A2 (0.46) MBOAT4KDM5CKDM5BKDM5AKDM5D
SCHEMBL6504215 0.76 LOX (0.48) CDK8CCNCKDM5CKDM5BKDM5A
Acetonitrile SCHEMBL21495142 0.75 CYP11B1 (0.44) CDK8CCNCKDM5CKDM5BKDM4B
SCHEMBL7668183 0.74 CYP1A2 (0.47) MBOAT4KDM5CKDM5BKDM5AKDM5D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101679418-A [2,6] naphthyridines compounds as protein kinase inhibitors NOVARTIS AG 2010-03-24 CN disclosed